← FDA Drug Approvals (Drugs@FDA)

TERIPARATIDE

NDA · New Drug Application · Sponsor: ALMAJECT · Approved 2024-06-04

Drug application

FDA Application #

NDA218771

Application type

New Drug Application

Brand name

TERIPARATIDE

Generic name

Teriparatide

Active ingredients

TERIPARATIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ALMAJECT

First approval

2024-06-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown